GP-ACT III ACQUISITION-A

GPATNASDAQ

🏆 #2893 by market capUS Equity

$10.91▼ $0.01 (−0.09%)

Live

1h—

24h▼ 0.1%

7d▲ 0.0%

14d▲ 0.0%

30d▼ 0.1%

1y▲ 3.4%

🏦Market Cap

$392M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Fair

Trading Snapshot

Day Range: $10.84 – $11.01
52-Week Range: $10.50 – $12.00
Volume: $2.72B
Avg Volume: $2.62B
Shares Outstanding: 35.9M
Next Earnings: Oct 10, 2026

Fundamentals Snapshot

Annual Revenue: $28M
Last Q Revenue: $8M
P/E Ratio: 36.0
P/S Ratio: —
EPS (TTM): $0.31
Dividend Yield: —

Why Investors Own GPAT

✓High-growth profile — revenue up +12.2% YoY with expanding US Equity exposure.
✓Healthy economics — 47% gross margin and 26% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$28M▲ +6.6% YoY

Gross Margin (TTM)

47.1%▲ +3.1% YoY

Operating Income (TTM)

$8M▲ +6.6% YoY

Free Cash Flow (TTM)

$7M▲ +6.6% YoY

About GP-ACT III ACQUISITION-A

GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. The company was incorporated in 2020 and is based in New York, New York.

🦦